Printer-friendly versionNew contraception, NuvaRing, harms women, but this isn't unusual. The FDA recently approved another method of contraception, the “NuvaRing” developed and marketed by Organon. The NuvaRing emits the hormones estrogen and progesterone in amounts similar to those found in birth control pills. Organon isn’t going to market the product immediately, first they plan to enroll up to 6,000 doctors in a pilot program that trains them in how to use NuvaRing and provides each with a small number of devices.  Doctors will have the opportunity to ‘practice’ putting them in place on women before Organon starts advertising them. Side effects from the use of the ring include discharge, irritation of infection and in clinical trials, about 14 percent of the users had vaginitis.  Associated Press article in Pittsburgh Post-Gazette, 10/4/01